Cargando…
Pharmacogenetics of Vascular Risk Factors in Alzheimer’s Disease
Alzheimer’s disease (AD) is a polygenic/complex disorder in which genomic, epigenomic, cerebrovascular, metabolic, and environmental factors converge to define a progressive neurodegenerative phenotype. Pharmacogenetics is a major determinant of therapeutic outcome in AD. Different categories of gen...
Autores principales: | Cacabelos, Ramón, Meyyazhagan, Arun, Carril, Juan C., Cacabelos, Pablo, Teijido, Óscar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872077/ https://www.ncbi.nlm.nih.gov/pubmed/29301387 http://dx.doi.org/10.3390/jpm8010003 |
Ejemplares similares
-
Population-based Study of Risk Polymorphisms Associated with Vascular Disorders and Dementia
por: Teijido, Óscar, et al.
Publicado: (2017) -
Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer’s and Parkinson’s Diseases
por: Teijido, Oscar, et al.
Publicado: (2018) -
Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer’s Disease
por: Cacabelos, Ramón, et al.
Publicado: (2021) -
Optimization of Antidepressant use with Pharmacogenetic Strategies
por: Torrellas, Clara, et al.
Publicado: (2017) -
Donepezil in Alzheimer’s disease: From conventional trials to pharmacogenetics
por: Cacabelos, Ramón
Publicado: (2007)